Is Gillespie syndrome hereditary?

Gillespie syndrome is a rare genetic condition primarily caused by heterozygous pathogenic variants in the PAX6 gene, which are typically inherited in an autosomal dominant pattern. While it is hereditary, many cases of Gillespie syndrome arise from de novo (spontaneous) mutations, meaning the affected individual is the first in their family to carry the genetic change.

Is Gillespie syndrome hereditary?

Gillespie syndrome is considered a genetic condition. In clinical genetics, we distinguish between "genetic"—meaning caused by a change in DNA—and "hereditary"—meaning the condition can be passed from parent to child. Gillespie syndrome is both. The condition is characterized by partial aniridia (absence of part of the iris), cerebellar ataxia, and intellectual disability. Because it follows an autosomal dominant inheritance pattern, an affected parent has a 50% chance of passing the PAX6 mutation to each child. However, due to the high frequency of de novo mutations, many patients diagnosed with Gillespie syndrome have parents who do not carry the genetic variant.

What causes the genetic changes in Gillespie syndrome?

The primary driver of Gillespie syndrome is a mutation in the PAX6 gene located on chromosome 11. Unlike classic aniridia, which is often associated with a wide range of ocular defects, the specific mutations in Gillespie syndrome appear to have a unique effect on the development of the iris stroma and the cerebellum. Clinical geneticists emphasize that not all PAX6 mutations result in the same phenotype; therefore, precise molecular testing is essential to confirm the diagnosis of Gillespie syndrome versus other PAX6-related disorders.

How is genetic testing and counseling utilized?

Genetic testing for Gillespie syndrome is available through targeted gene sequencing or larger multi-gene panels that include PAX6. Genetic counseling is strongly recommended for families following a diagnosis for the following reasons:

• Confirmation of origin: Parental testing can determine if the mutation was inherited or if it occurred de novo, which significantly alters recurrence risk for future pregnancies.


• Reproductive planning: For parents who carry a PAX6 mutation, options such as In Vitro Fertilization (IVF) with Preimplantation Genetic Testing (PGT) can be discussed.


• Family screening: Because Gillespie syndrome can present with varying degrees of severity, testing may be recommended for siblings or other relatives who may be at risk.

What is the role of the DiseaseMaps community?

As of our latest data, 9 people with Gillespie syndrome have joined the DiseaseMaps community. Connecting with others through platforms like DiseaseMaps.org can provide invaluable support for families navigating the complexities of a rare genetic diagnosis. Sharing experiences regarding clinical management and genetic testing journeys helps reduce the isolation often felt by those affected by this rare condition.

Next steps

• Consult a clinical geneticist to discuss molecular testing and the specific PAX6 variant identified.


• Request a referral to a genetic counselor to map out family history and discuss reproductive options.


• Join the Gillespie syndrome community on DiseaseMaps.org to connect with other families and share resources.


• Schedule regular evaluations with a pediatric neurologist and an ophthalmologist experienced in rare developmental syndromes.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any medical diagnosis or treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Gillespie Syndrome.


• Orphanet: Rare Disease Database, Entry for Gillespie Syndrome (ORPHA:93928).


• OMIM (Online Mendelian Inheritance in Man): Aniridia, Cerebellar Ataxia, and Mental Deficiency (Gillespie Syndrome).